Article Text
PostScript
Letter
Authors’ reply
Statistics from Altmetric.com
We appreciate the comments by Fujii and colleagues in reference to our manuscript on the development and validation of the BARD score for identifying patients with non-alcoholic steatohepatitis (NASH) without advanced fibrosis1 and applaud efforts by other investigators to apply the BARD score to their patient populations. The authors conclude that in a study of 122 Japanese patients with non-alcoholic fatty liver …
Footnotes
Competing interests None.
Provenance and Peer review Not commissioned; not externally peer reviewed.